Biologics and Biosimilars Market - Global Outlook and Forecast 2022-2028

Biologics and Biosimilars Market - Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Biologics and Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biologics and Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biologics and Biosimilars Overall Market Size
2.1 Global Biologics and Biosimilars Market Size: 2021 VS 2028
2.2 Global Biologics and Biosimilars Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Biologics and Biosimilars Sales: 2017-2028
3 Company Landscape
3.1 Top Biologics and Biosimilars Players in Global Market
3.2 Top Global Biologics and Biosimilars Companies Ranked by Revenue
3.3 Global Biologics and Biosimilars Revenue by Companies
3.4 Global Biologics and Biosimilars Sales by Companies
3.5 Global Biologics and Biosimilars Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Biologics and Biosimilars Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Biologics and Biosimilars Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biologics and Biosimilars Players in Global Market
3.8.1 List of Global Tier 1 Biologics and Biosimilars Companies
3.8.2 List of Global Tier 2 and Tier 3 Biologics and Biosimilars Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Biologics and Biosimilars Market Size Markets, 2021 & 2028
4.1.2 Monoclonal Antibodies
4.1.3 Interferon
4.1.4 Erythropoietin
4.1.5 Insulin
4.1.6 Vaccines
4.1.7 Others
4.2 By Type - Global Biologics and Biosimilars Revenue & Forecasts
4.2.1 By Type - Global Biologics and Biosimilars Revenue, 2017-2022
4.2.2 By Type - Global Biologics and Biosimilars Revenue, 2023-2028
4.2.3 By Type - Global Biologics and Biosimilars Revenue Market Share, 2017-2028
4.3 By Type - Global Biologics and Biosimilars Sales & Forecasts
4.3.1 By Type - Global Biologics and Biosimilars Sales, 2017-2022
4.3.2 By Type - Global Biologics and Biosimilars Sales, 2023-2028
4.3.3 By Type - Global Biologics and Biosimilars Sales Market Share, 2017-2028
4.4 By Type - Global Biologics and Biosimilars Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Biologics and Biosimilars Market Size, 2021 & 2028
5.1.2 Tumor
5.1.3 Diabetes
5.1.4 Cardiovascular
5.1.5 Hemophilia
5.1.6 Others
5.2 By Application - Global Biologics and Biosimilars Revenue & Forecasts
5.2.1 By Application - Global Biologics and Biosimilars Revenue, 2017-2022
5.2.2 By Application - Global Biologics and Biosimilars Revenue, 2023-2028
5.2.3 By Application - Global Biologics and Biosimilars Revenue Market Share, 2017-2028
5.3 By Application - Global Biologics and Biosimilars Sales & Forecasts
5.3.1 By Application - Global Biologics and Biosimilars Sales, 2017-2022
5.3.2 By Application - Global Biologics and Biosimilars Sales, 2023-2028
5.3.3 By Application - Global Biologics and Biosimilars Sales Market Share, 2017-2028
5.4 By Application - Global Biologics and Biosimilars Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Biologics and Biosimilars Market Size, 2021 & 2028
6.2 By Region - Global Biologics and Biosimilars Revenue & Forecasts
6.2.1 By Region - Global Biologics and Biosimilars Revenue, 2017-2022
6.2.2 By Region - Global Biologics and Biosimilars Revenue, 2023-2028
6.2.3 By Region - Global Biologics and Biosimilars Revenue Market Share, 2017-2028
6.3 By Region - Global Biologics and Biosimilars Sales & Forecasts
6.3.1 By Region - Global Biologics and Biosimilars Sales, 2017-2022
6.3.2 By Region - Global Biologics and Biosimilars Sales, 2023-2028
6.3.3 By Region - Global Biologics and Biosimilars Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Biologics and Biosimilars Revenue, 2017-2028
6.4.2 By Country - North America Biologics and Biosimilars Sales, 2017-2028
6.4.3 US Biologics and Biosimilars Market Size, 2017-2028
6.4.4 Canada Biologics and Biosimilars Market Size, 2017-2028
6.4.5 Mexico Biologics and Biosimilars Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Biologics and Biosimilars Revenue, 2017-2028
6.5.2 By Country - Europe Biologics and Biosimilars Sales, 2017-2028
6.5.3 Germany Biologics and Biosimilars Market Size, 2017-2028
6.5.4 France Biologics and Biosimilars Market Size, 2017-2028
6.5.5 U.K. Biologics and Biosimilars Market Size, 2017-2028
6.5.6 Italy Biologics and Biosimilars Market Size, 2017-2028
6.5.7 Russia Biologics and Biosimilars Market Size, 2017-2028
6.5.8 Nordic Countries Biologics and Biosimilars Market Size, 2017-2028
6.5.9 Benelux Biologics and Biosimilars Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Biologics and Biosimilars Revenue, 2017-2028
6.6.2 By Region - Asia Biologics and Biosimilars Sales, 2017-2028
6.6.3 China Biologics and Biosimilars Market Size, 2017-2028
6.6.4 Japan Biologics and Biosimilars Market Size, 2017-2028
6.6.5 South Korea Biologics and Biosimilars Market Size, 2017-2028
6.6.6 Southeast Asia Biologics and Biosimilars Market Size, 2017-2028
6.6.7 India Biologics and Biosimilars Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Biologics and Biosimilars Revenue, 2017-2028
6.7.2 By Country - South America Biologics and Biosimilars Sales, 2017-2028
6.7.3 Brazil Biologics and Biosimilars Market Size, 2017-2028
6.7.4 Argentina Biologics and Biosimilars Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biologics and Biosimilars Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Biologics and Biosimilars Sales, 2017-2028
6.8.3 Turkey Biologics and Biosimilars Market Size, 2017-2028
6.8.4 Israel Biologics and Biosimilars Market Size, 2017-2028
6.8.5 Saudi Arabia Biologics and Biosimilars Market Size, 2017-2028
6.8.6 UAE Biologics and Biosimilars Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Biologics and Biosimilars Major Product Offerings
7.1.4 Roche Biologics and Biosimilars Sales and Revenue in Global (2017-2022)
7.1.5 Roche Key News
7.2 Amgen
7.2.1 Amgen Corporate Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Biologics and Biosimilars Major Product Offerings
7.2.4 Amgen Biologics and Biosimilars Sales and Revenue in Global (2017-2022)
7.2.5 Amgen Key News
7.3 AbbVie
7.3.1 AbbVie Corporate Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Biologics and Biosimilars Major Product Offerings
7.3.4 AbbVie Biologics and Biosimilars Sales and Revenue in Global (2017-2022)
7.3.5 AbbVie Key News
7.4 Sanofi-Aventis
7.4.1 Sanofi-Aventis Corporate Summary
7.4.2 Sanofi-Aventis Business Overview
7.4.3 Sanofi-Aventis Biologics and Biosimilars Major Product Offerings
7.4.4 Sanofi-Aventis Biologics and Biosimilars Sales and Revenue in Global (2017-2022)
7.4.5 Sanofi-Aventis Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Biologics and Biosimilars Major Product Offerings
7.5.4 Johnson & Johnson Biologics and Biosimilars Sales and Revenue in Global (2017-2022)
7.5.5 Johnson & Johnson Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Biologics and Biosimilars Major Product Offerings
7.6.4 Pfizer Biologics and Biosimilars Sales and Revenue in Global (2017-2022)
7.6.5 Pfizer Key News
7.7 Novo Nordisk
7.7.1 Novo Nordisk Corporate Summary
7.7.2 Novo Nordisk Business Overview
7.7.3 Novo Nordisk Biologics and Biosimilars Major Product Offerings
7.7.4 Novo Nordisk Biologics and Biosimilars Sales and Revenue in Global (2017-2022)
7.7.5 Novo Nordisk Key News
7.8 Eli Lilly
7.8.1 Eli Lilly Corporate Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Biologics and Biosimilars Major Product Offerings
7.8.4 Eli Lilly Biologics and Biosimilars Sales and Revenue in Global (2017-2022)
7.8.5 Eli Lilly Key News
7.9 Novartis
7.9.1 Novartis Corporate Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Biologics and Biosimilars Major Product Offerings
7.9.4 Novartis Biologics and Biosimilars Sales and Revenue in Global (2017-2022)
7.9.5 Novartis Key News
7.10 Merck
7.10.1 Merck Corporate Summary
7.10.2 Merck Business Overview
7.10.3 Merck Biologics and Biosimilars Major Product Offerings
7.10.4 Merck Biologics and Biosimilars Sales and Revenue in Global (2017-2022)
7.10.5 Merck Key News
7.11 3sbio
7.11.1 3sbio Corporate Summary
7.11.2 3sbio Biologics and Biosimilars Business Overview
7.11.3 3sbio Biologics and Biosimilars Major Product Offerings
7.11.4 3sbio Biologics and Biosimilars Sales and Revenue in Global (2017-2022)
7.11.5 3sbio Key News
7.12 Changchun High Tech
7.12.1 Changchun High Tech Corporate Summary
7.12.2 Changchun High Tech Biologics and Biosimilars Business Overview
7.12.3 Changchun High Tech Biologics and Biosimilars Major Product Offerings
7.12.4 Changchun High Tech Biologics and Biosimilars Sales and Revenue in Global (2017-2022)
7.12.5 Changchun High Tech Key News
7.13 CP Guojian
7.13.1 CP Guojian Corporate Summary
7.13.2 CP Guojian Biologics and Biosimilars Business Overview
7.13.3 CP Guojian Biologics and Biosimilars Major Product Offerings
7.13.4 CP Guojian Biologics and Biosimilars Sales and Revenue in Global (2017-2022)
7.13.5 CP Guojian Key News
7.14 Biotech
7.14.1 Biotech Corporate Summary
7.14.2 Biotech Business Overview
7.14.3 Biotech Biologics and Biosimilars Major Product Offerings
7.14.4 Biotech Biologics and Biosimilars Sales and Revenue in Global (2017-2022)
7.14.5 Biotech Key News
7.15 Gelgen
7.15.1 Gelgen Corporate Summary
7.15.2 Gelgen Business Overview
7.15.3 Gelgen Biologics and Biosimilars Major Product Offerings
7.15.4 Gelgen Biologics and Biosimilars Sales and Revenue in Global (2017-2022)
7.15.5 Gelgen Key News
7.16 Innovent
7.16.1 Innovent Corporate Summary
7.16.2 Innovent Business Overview
7.16.3 Innovent Biologics and Biosimilars Major Product Offerings
7.16.4 Innovent Biologics and Biosimilars Sales and Revenue in Global (2017-2022)
7.16.5 Innovent Key News
7.17 Dong Bao
7.17.1 Dong Bao Corporate Summary
7.17.2 Dong Bao Business Overview
7.17.3 Dong Bao Biologics and Biosimilars Major Product Offerings
7.17.4 Dong Bao Biologics and Biosimilars Sales and Revenue in Global (2017-2022)
7.17.5 Dong Bao Key News
7.18 Ganlee
7.18.1 Ganlee Corporate Summary
7.18.2 Ganlee Business Overview
7.18.3 Ganlee Biologics and Biosimilars Major Product Offerings
7.18.4 Ganlee Biologics and Biosimilars Sales and Revenue in Global (2017-2022)
7.18.5 Ganlee Key News
7.19 United Laboratories
7.19.1 United Laboratories Corporate Summary
7.19.2 United Laboratories Business Overview
7.19.3 United Laboratories Biologics and Biosimilars Major Product Offerings
7.19.4 United Laboratories Biologics and Biosimilars Sales and Revenue in Global (2017-2022)
7.19.5 United Laboratories Key News
8 Global Biologics and Biosimilars Production Capacity, Analysis
8.1 Global Biologics and Biosimilars Production Capacity, 2017-2028
8.2 Biologics and Biosimilars Production Capacity of Key Manufacturers in Global Market
8.3 Global Biologics and Biosimilars Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biologics and Biosimilars Supply Chain Analysis
10.1 Biologics and Biosimilars Industry Value Chain
10.2 Biologics and Biosimilars Upstream Market
10.3 Biologics and Biosimilars Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biologics and Biosimilars Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Biologics and Biosimilars in Global Market
Table 2. Top Biologics and Biosimilars Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Biologics and Biosimilars Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Biologics and Biosimilars Revenue Share by Companies, 2017-2022
Table 5. Global Biologics and Biosimilars Sales by Companies, (K Units), 2017-2022
Table 6. Global Biologics and Biosimilars Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Biologics and Biosimilars Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Biologics and Biosimilars Product Type
Table 9. List of Global Tier 1 Biologics and Biosimilars Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biologics and Biosimilars Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Biologics and Biosimilars Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Biologics and Biosimilars Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Biologics and Biosimilars Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Biologics and Biosimilars Sales (K Units), 2017-2022
Table 15. By Type - Global Biologics and Biosimilars Sales (K Units), 2023-2028
Table 16. By Application - Global Biologics and Biosimilars Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Biologics and Biosimilars Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Biologics and Biosimilars Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Biologics and Biosimilars Sales (K Units), 2017-2022
Table 20. By Application - Global Biologics and Biosimilars Sales (K Units), 2023-2028
Table 21. By Region - Global Biologics and Biosimilars Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Biologics and Biosimilars Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Biologics and Biosimilars Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Biologics and Biosimilars Sales (K Units), 2017-2022
Table 25. By Region - Global Biologics and Biosimilars Sales (K Units), 2023-2028
Table 26. By Country - North America Biologics and Biosimilars Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Biologics and Biosimilars Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Biologics and Biosimilars Sales, (K Units), 2017-2022
Table 29. By Country - North America Biologics and Biosimilars Sales, (K Units), 2023-2028
Table 30. By Country - Europe Biologics and Biosimilars Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Biologics and Biosimilars Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Biologics and Biosimilars Sales, (K Units), 2017-2022
Table 33. By Country - Europe Biologics and Biosimilars Sales, (K Units), 2023-2028
Table 34. By Region - Asia Biologics and Biosimilars Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Biologics and Biosimilars Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Biologics and Biosimilars Sales, (K Units), 2017-2022
Table 37. By Region - Asia Biologics and Biosimilars Sales, (K Units), 2023-2028
Table 38. By Country - South America Biologics and Biosimilars Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Biologics and Biosimilars Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Biologics and Biosimilars Sales, (K Units), 2017-2022
Table 41. By Country - South America Biologics and Biosimilars Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Biologics and Biosimilars Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Biologics and Biosimilars Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Biologics and Biosimilars Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Biologics and Biosimilars Sales, (K Units), 2023-2028
Table 46. Roche Corporate Summary
Table 47. Roche Biologics and Biosimilars Product Offerings
Table 48. Roche Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Amgen Corporate Summary
Table 50. Amgen Biologics and Biosimilars Product Offerings
Table 51. Amgen Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. AbbVie Corporate Summary
Table 53. AbbVie Biologics and Biosimilars Product Offerings
Table 54. AbbVie Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Sanofi-Aventis Corporate Summary
Table 56. Sanofi-Aventis Biologics and Biosimilars Product Offerings
Table 57. Sanofi-Aventis Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Johnson & Johnson Corporate Summary
Table 59. Johnson & Johnson Biologics and Biosimilars Product Offerings
Table 60. Johnson & Johnson Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Pfizer Corporate Summary
Table 62. Pfizer Biologics and Biosimilars Product Offerings
Table 63. Pfizer Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Novo Nordisk Corporate Summary
Table 65. Novo Nordisk Biologics and Biosimilars Product Offerings
Table 66. Novo Nordisk Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Eli Lilly Corporate Summary
Table 68. Eli Lilly Biologics and Biosimilars Product Offerings
Table 69. Eli Lilly Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Novartis Corporate Summary
Table 71. Novartis Biologics and Biosimilars Product Offerings
Table 72. Novartis Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Merck Corporate Summary
Table 74. Merck Biologics and Biosimilars Product Offerings
Table 75. Merck Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. 3sbio Corporate Summary
Table 77. 3sbio Biologics and Biosimilars Product Offerings
Table 78. 3sbio Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Changchun High Tech Corporate Summary
Table 80. Changchun High Tech Biologics and Biosimilars Product Offerings
Table 81. Changchun High Tech Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. CP Guojian Corporate Summary
Table 83. CP Guojian Biologics and Biosimilars Product Offerings
Table 84. CP Guojian Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. Biotech Corporate Summary
Table 86. Biotech Biologics and Biosimilars Product Offerings
Table 87. Biotech Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. Gelgen Corporate Summary
Table 89. Gelgen Biologics and Biosimilars Product Offerings
Table 90. Gelgen Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 91. Innovent Corporate Summary
Table 92. Innovent Biologics and Biosimilars Product Offerings
Table 93. Innovent Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 94. Dong Bao Corporate Summary
Table 95. Dong Bao Biologics and Biosimilars Product Offerings
Table 96. Dong Bao Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 97. Ganlee Corporate Summary
Table 98. Ganlee Biologics and Biosimilars Product Offerings
Table 99. Ganlee Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 100. United Laboratories Corporate Summary
Table 101. United Laboratories Biologics and Biosimilars Product Offerings
Table 102. United Laboratories Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 103. Biologics and Biosimilars Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 104. Global Biologics and Biosimilars Capacity Market Share of Key Manufacturers, 2020-2022
Table 105. Global Biologics and Biosimilars Production by Region, 2017-2022 (K Units)
Table 106. Global Biologics and Biosimilars Production by Region, 2023-2028 (K Units)
Table 107. Biologics and Biosimilars Market Opportunities & Trends in Global Market
Table 108. Biologics and Biosimilars Market Drivers in Global Market
Table 109. Biologics and Biosimilars Market Restraints in Global Market
Table 110. Biologics and Biosimilars Raw Materials
Table 111. Biologics and Biosimilars Raw Materials Suppliers in Global Market
Table 112. Typical Biologics and Biosimilars Downstream
Table 113. Biologics and Biosimilars Downstream Clients in Global Market
Table 114. Biologics and Biosimilars Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Biologics and Biosimilars Segment by Type
Figure 2. Biologics and Biosimilars Segment by Application
Figure 3. Global Biologics and Biosimilars Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Biologics and Biosimilars Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biologics and Biosimilars Revenue, 2017-2028 (US$, Mn)
Figure 7. Biologics and Biosimilars Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Biologics and Biosimilars Revenue in 2021
Figure 9. By Type - Global Biologics and Biosimilars Sales Market Share, 2017-2028
Figure 10. By Type - Global Biologics and Biosimilars Revenue Market Share, 2017-2028
Figure 11. By Type - Global Biologics and Biosimilars Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Biologics and Biosimilars Sales Market Share, 2017-2028
Figure 13. By Application - Global Biologics and Biosimilars Revenue Market Share, 2017-2028
Figure 14. By Application - Global Biologics and Biosimilars Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Biologics and Biosimilars Sales Market Share, 2017-2028
Figure 16. By Region - Global Biologics and Biosimilars Revenue Market Share, 2017-2028
Figure 17. By Country - North America Biologics and Biosimilars Revenue Market Share, 2017-2028
Figure 18. By Country - North America Biologics and Biosimilars Sales Market Share, 2017-2028
Figure 19. US Biologics and Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Biologics and Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Biologics and Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Biologics and Biosimilars Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Biologics and Biosimilars Sales Market Share, 2017-2028
Figure 24. Germany Biologics and Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 25. France Biologics and Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Biologics and Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Biologics and Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Biologics and Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Biologics and Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Biologics and Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Biologics and Biosimilars Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Biologics and Biosimilars Sales Market Share, 2017-2028
Figure 33. China Biologics and Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Biologics and Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Biologics and Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Biologics and Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 37. India Biologics and Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Biologics and Biosimilars Revenue Market Share, 2017-2028
Figure 39. By Country - South America Biologics and Biosimilars Sales Market Share, 2017-2028
Figure 40. Brazil Biologics and Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Biologics and Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Biologics and Biosimilars Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Biologics and Biosimilars Sales Market Share, 2017-2028
Figure 44. Turkey Biologics and Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Biologics and Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Biologics and Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Biologics and Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 48. Global Biologics and Biosimilars Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Biologics and Biosimilars by Region, 2020 VS 2027
Figure 50. Biologics and Biosimilars Industry Value Chain
Figure 51. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147

According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......

Global Biosimilar Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147

According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......

Global Biosimilars Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......

Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs